Quynh-Nhu Nguyen

  1. He K, Hong DS, Tang C, Sezen D, Cox L, Maleki A, Bertolet G, Nguyen QN, Comeaux NI, Schuda L, Chen D, Welsh JW

    . Five-Year Overall Survival with Ipilimumab and Stereotactic Ablative Radiotherapy for Metastatic Disease. Radiother Oncol 183:109618. e-Pub 2023. PMID: 36921766.

  2. Geng H, Liao Z, Nguyen QN, Berman AT, Robinson C, Wu A, Nichols RC, Willers H, Mohammed N, Mohindra P, Xiao Y

    . Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study. Cancers (Basel) 15(4), 2023. e-Pub 2023. PMID: 36831358.

  3. Betancourt Cuellar SL, Benveniste MF, Truong M, Nguyen QN, Atiyah A, Hofstetter WL, Erasmus JJ

    . Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy: Systematic Review of FDG-PET/CT Patterns. Am J Clin Oncol 46(1):25-30, 2023. e-Pub 2022. PMID: 36562692.

  4. Vassilakopoulou M, Chen H-C, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Matamoros, Jr A, Sagebiel T, Devine C, Thomas I, Sanders EM, Shanbhag N, Rogers JE, Lee JH, Weston B, Bhutani MS, Hofstetter W, Nguyen QN, Badgwell BD, Ajani JA

    . Localized gastroesophageal adenocarcinoma in the elderly: is age a factor associated with suboptimal treatment?. Oncology. e-Pub 2022. PMID: 36412619.

  5. Xu T, Wu L, Gandhi S, Jing W, Nguyen QN, Chen A, Chang JY, Nurieva R, Sheshadri A, Altan M, Lee PP, Lin SH, Liao Z

    . Treatment Related Pulmonary Adverse Events Induced by Chemoradiation and Durvalumab Affect Survival in Locally Advanced Non-Small Cell Lung Cancer. Radiother Oncol 176:149-156. e-Pub 2022. PMID: 36209942.

  6. Chen M, Wang Z, Jiang S, Sun J, Wang L, Sahoo N, Gunn GB, Frank SJ, Xu C, Chen J, Nguyen QN, Chang JY, Liao Z, Ronald Zhu X, Zhang X

    . Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy. Sci Rep 12(1):9178, 2022. e-Pub 2022. PMID: 35655073.

  7. De B, Fu S, Chen YS, Das P, Ku K, Maroongroge S, Woodhouse KD, Hoffman KE, Nguyen QN, Reed VK, Chen AB, Koong AC, Smith BD, Smith GL

    . Patient, physician, and policy factors underlying variation in use of telemedicine for radiation oncology cancer care. Cancer Med 11(10):2096-2105, 2022. e-Pub 2022. PMID: 35297210.

  8. Antonoff MB, Sofocleous CT, Callstrom MR, Nguyen QN

    . The Roles of Surgery, Stereotactic Radiation, and Ablation for Treatment of Pulmonary Metastases. J Thorac Cardiovasc Surg 163(2):495-502, 2022. e-Pub 2021. PMID: 33838914.

  9. Strange CD, Shroff GS, Truong MT, Nguyen QN, Vlahos I, Erasmus JJ

    . Imaging of the post-radiation chest in lung cancer. Clin Radiol 77(1):19-30, 2022. e-Pub 2021. PMID: 34090709.

  10. Hu Y, Paris S, Barsoumian H, Abana CO, He K, Sezen D, Wasley M, Masrorpour F, Chen D, Yang L, Dunn JD, Gandhi S, Nguyen QN, Cortez MA, Welsh JW

    . A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model. J Nanobiotechnology 19(1):416, 2021. e-Pub 2021. PMID: 34895262.

  11. Hu Y, Paris S, Barsoumian H, Abana CO, He K, Wasley M, Younes AI, Masrorpour F, Chen D, Yang L, Dunn JD, Zhang J, Gandhi S, Nguyen QN, Cortez MA, Welsh J

    . Radiotherapy enhanced by NBTXR3 nanoparticles overcomes anti-PD1 resistance and evokes abscopal effects. Int J Radiat Oncol Biol Phys 111(3):647-657, 2021. e-Pub 2021. PMID: 34242713.

  12. Nguyen QN

    . Errors in Reported Primary and Secondary Outcomes and Table Numbers in a Trial of Radiotherapy for Pain Relief in Patients With Bone Metastases. JAMA Oncol 7(10):1576-1577, 2021. e-Pub 2021. PMID: 34383007.

  13. Boyce-Fappiano D, Nguyen QN, Chapman BV, Allen PK, Gjyshi O, Pezzi TA, De B, Gomez D, Lin SH, Chang JY, Liao Z, Lee P, Gandhi SJ

    . Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer. Clin Lung Cancer 22(5):e745-e755, 2021. e-Pub 2021. PMID: 33707003.

  14. Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O’Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA, STARS Lung Cancer Trials Group

    . Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol. e-Pub 2021. PMID: 34529930.

  15. Jing W, Liu Y, Zhu H, Welsh J, Gandhi S, Jeter M, Nguyen QN, Chen AB, O’Reilly M, Liao Z, Chang JY, Lee P, Lin SH

    . Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study. Clin Transl Radiat Oncol 28:54-61, 2021. e-Pub 2021. PMID: 33778173.

  16. Grant SR, Smith BD, Colbert LE, Nguyen QN, Yu JB, Lin SH, Chen AB

    . National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non-Small Cell Lung Cancer. J Natl Compr Canc Netw:1-6. e-Pub 2021. PMID: 34044365.

  17. Ajani JA, Harada K, Hwang H, Wang X, Abdelhakeem, AAF, Iwatsuki M, Blum Murphy M, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag ND, Zhao M, Bhutani M, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL

    . Frequency and Implications of paratracheal lymph node metastases in resectable esophageal or gastroesophageal junction adenocarcinoma. Ann Surg 273(4):751-757, 2021. e-Pub 2019. PMID: 31188215.

  18. Reichard CA, Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF

    . Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design. Eur Urol Focus 7(1):71-77, 2021. e-Pub 2019. PMID: 31076357.

  19. Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI, Morrison WH, Phan J, Garden AS, Welsh JW, Chang JY, Liao Z, Erasmus JJ, Nguyen QN

    . Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck 42(8):1939-1953, 2020. e-Pub 2020. PMID: 32129548.

  20. Abu-Gheida I, Bathala TK, Maldonado JA, Khan M, Anscher MS, Frank SJ, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Kim M, Kuban DA, Aparicio A, Chapin BF, Tang C

    . Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers. Int J Radiat Oncol Biol Phys 107(5):982-985, 2020. e-Pub 2020. PMID: 32353391.

  21. Mesko S, Ning MS, Lakomy D, Verma V, Chang JY, O’Reilly M, Jeter MD, Gandhi SJ, Lin SH, Nguyen QN, Liao Z, Welsh J, Chen AB, Hahn S, Gomez DR

    . Thoracic radiation oncology clinical trial accrual and reasons for non-enrollment: results of a large, prospective, multi-year analysis. Int J Radiat Oncol Biol Phys 107(5):897-908, 2020. e-Pub 2020. PMID: 32360653.

  22. Harada K, Wu CC, Wang X, Mizrak Kaya D, Amlashi FG, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JA

    . Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Ann Surg 272(2):311-318, 2020. PMID: 32675544.

  23. Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi B

    . Locoregional Control, Overall Survival and Disease-Free Survival in Stage IIIA (N2) Non-Small Cell Lung Cancer – An Analysis of Resected and Unresected Patients. Clin Lung Cancer 21(4):e294-e301, 2020. e-Pub 2020. PMID: 32089476.

  24. Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P

    . Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. PMID: 32775771.

  25. Davis JW, Ward JF, Pisters LL, Reichard CA, Wang X, Achim MF, Kuban DA, Choi S, Logothetis CJ, Troncoso P, Madsen LT, Babaian RJ, Nguyen QN, Kim J

    . Determining Clinically-Based Factors Associated with Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort. Urology 138:91-97, 2020. e-Pub 2019. PMID: 31899230.

  26. Bagley AF, Anscher MS, Choi S, Frank SJ, Hoffman KE, Kuban DA, McGuire SE, Nguyen QN, Chapin B, Aparicio A, Pezzi TA, Smith GL, Smith BD, Hess K, Tang C

    . Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer. JAMA Netw Open 3(3):e201255, 2020. e-Pub 2020. PMID: 32191331.

  27. Wang Z, Chen M, Sun J, Jiang S, Wang L, Wang X, Sahoo N, Gunn GB, Frank SJ, Nguyen QN, Liao Z, Chang JY, Zhu XR, Zhang X

    . Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy. Radiother Oncol 146:200-204. e-Pub 2020. PMID: 32220701.

  28. Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Nguyen QN, Antonoff MB

    . Surveillance after Treatment of Non-Small Cell Lung Cancer: A Call for Multidisciplinary Standardization. Innovations 15(1):57-65, 2020. e-Pub 2019. PMID: 31875755.

  29. Pasalic D, Betancourt-Cuellar S, Taku N, Mesko S, Bagley A, Chance W, Allen P, Tang C, Antonoff M, Mehran R, Welsh, J, Liao ZX, Gomez D, Erasmus J, Nguyen QN

    . Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Improving Overall Survival and Identifying Subgroups at High Risk of Local Failure. Radiat & Oncol 145:178-185, 2020. PMID: 32044530.

  30. Welsh JW, Heymach JV, Chen D, Verma V, Cushman TR, Hess KR, Shroff G, Tang C, Skoulidis F, Jeter M, Menon H, Nguyen QN, Chang JY, Altan M, Papadimitrakopoulou VA, Simon GR, Raju U, Byers L, Glisson B

    . Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer. J Thorac Oncol 15(2):266-273, 2020. e-Pub 2019. PMID: 31605794.

  31. Lopez A, Harada K, Chen HC, Bhutani MS, Weston B, Lee JH, Maru DM, Chin FW, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Zhao M, Hofstetter WL, Nguyen QN, Ajani JA

    . Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. Medicine (Baltimore) 99(9):e19295, 2020. PMID: 32118743.

  32. Grant SR, Lei X, Smith BS, Smith GL, Surena M, Wood C, Karam,JA, Nguyen QN, Frank SJ, Anscher MS

    . Stereotactic Body Radiotherapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison with Surgery, Tumor Ablation, and Observation Advances in Radiation Oncology. Advances in Radiation Oncology 5(3):495-502, 2020. PMID: 32529146.

  33. Nelson, D, Tayob N, Nguyen QN, Erasmus JJ, Mitchell KG, Hofstetter WL, Sepesi B, Antonoff MB; Mehran RJ

    . Local Failure after Stereotactic Body Radiation Therapy or Wedge Resection for Colorectal Pulmonary Metastases. J Thoracic and Cardiovascular Surgery 158(4):1234-1241, 2019. e-Pub 2019. PMID: 31395367.

  34. Welsh J, Tang C, de Groot P, Naing A, Hess K, Heymach J, Papadimitrakopoulou V, Cushman T, Subbiah V, Chang J, Simon G, Ramapriyan R, Barsoumian H, Menon H, Cortez M, Massarelli E, Nguyen QN, Sharma P, Allison J, Diab A, Verma V, Raju U, Shaaban S, Dadu R, Cabanillas M, Wang K, Anderson C, Gomez D, Hahn S, Komaki R, Hong D

    . Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses. Cancer Immunology Research 7(12):1903-1909. e-Pub 2019. PMID: 31658994.

  35. Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW

    . Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol 5(11):1597-1604, 2019. e-Pub 2019. PMID: 31529018.

  36. Caetano MS, Younes AI, Barsoumian HB, Quigley M, Menon H, Gao C, Spires TE, Reilly TP, Cadena AP, Cushman TR, Schoenhals JE, Li A, Nguyen QN, Cortez MA, Welsh JW

    . Triple Therapy with MerTK and PD1 Inhibition plus Radiotherapy Promotes Abscopal Antitumor Immune Responses. Clin Cancer Res 25(24):7576-7584. e-Pub 2019. PMID: 31540976.

  37. Pasalic D, Kuban DA, Allen PK, Tang C, Mesko SM, Grant SR, Augustyn AA, Frank SJ, Choi S, Hoffman KE, Nguyen QN, McGuire SE, Pollack A, Anscher MS

    . Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase III, Single Institution Randomized Clinical Trial. Int J Radiat Oncol Biol Phys 104(4):790-797, 2019. e-Pub 2019. PMID: 30836166.

  38. Nguyen QN, Chun SG, Chow E, Komaki R, Liao Z, Zacharia R, Szeto BK, Welsh JW, Hahn SM, Fuller CD, Moon BS, Bird JE, Satcher R, Lin PP, Jeter M, O’Reilly MS, Lewis VO

    . Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial. JAMA Oncol 5(6):872-878, 2019. e-Pub 2019. PMID: 31021390.

  39. Elhammali A, Blanchard P, Yoder A, Liao Z, Zhang X, Ronald Zhu X, Allen PK, Jeter M, Welsh J, Nguyen QN

    . Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer. Radiother Oncol 136:136-142, 2019. e-Pub 2019. PMID: 31015115.

  40. Harada K, Wu CC, Wang X, Mizrak Kaya D, Amlashi FG, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JA

    . Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Ann Surg. e-Pub 2019. PMID: 30720506.

  41. Niknam S, Barsoumian HB, Schoenhals JE, Jackson H, Yanamandra N, Caetano MS, Li A, Younes AI, Cadena AP, Cushman TR, Chang JY, Nguyen QN, Gomez DR, Diab A, Heymach JV, Hwu P, Cortez MA, Welsh JW

    . Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor model. Clin Cancer Res 24(22):5735-5743, 2018. e-Pub 2018. PMID: 29784675.

  42. Hoffman KE, Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen QN, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA

    . Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. J Clin Oncol 36(29):2943-2949, 2018. e-Pub 2018. PMID: 30106637.

  43. Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O’Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY

    . Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. JAMA Netw Open 1(4):e181390, 2018. e-Pub 2018. PMID: 30646121.

  44. Nantavithya C, Gomez DR, Wei X, Komaki R, Liao Z, Lin SH, Jeter M, Nguyen QN, Li H, Zhang X, Poenisch F, Zhu XR, Balter PA, Feng L, Choi NC, Mohan R, Chang JY

    . Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 101(3):558-563, 2018. e-Pub 2018. PMID: 29680255.

  45. Pan HY, Jiang J, Hoffman KE, Tang C, Choi SL, Nguyen QN, Frank SJ, Anscher MS, Shih YT, Smith BD

    . Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. J Clin Oncol 36(18):1823-1830, 2018. e-Pub 2018. PMID: 29561693.

  46. Yang J, Xu T, Gomez D, Yuan X, Nguyen QN, Jeter M, Song Y, Komaki R, Hu Y, Hahn SM, Liao Z

    . Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer. Cancer Med 7(6):2247-2255, 2018. e-Pub 2018. PMID: 29745043.

  47. Jeter MD, Gomez D, Nguyen QN, Komaki R, Zhang X, Zhu X, O’Reilly M, Fossella FV, Xu T, Wei X, Wang H, Yang W, Tsao A, Mohan R, Liao Z

    . Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study. Int J Radiat Oncol Biol Phys 100(3):730-737, 2018. e-Pub 2017. PMID: 29248169.

  48. Lopez Guerra JL, Song YP, Nguyen QN, Gomez DR, Liao Z, Xu T

    . Functional Promotor rs-189037 variant of ATM is associated with decreasing lung diffusing capacity after irradiation for non-small cell lung cancer. Chronic Dis Transl Med 4(1):59-66, 2018.

  49. Zhou R, Xu T, Nguyen QN, Liu Y, Yang J, Komaki R, Gomez DR, Liao Z

    . Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 100(2):452-461, 2018. e-Pub 2017. PMID: 29174428.

  50. Hong J, Liao Z, Zhuang Y, Levy LB, Sheu T, Heymach JV, Nguyen QN, Xu T, Komaki R, Gomez DR

    . Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis. Am J Clin Oncol 41(1):46-52, 2018. e-Pub 2015. PMID: 26535988.

  51. Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen QN, McGuire SE, Mahmood U, Frank SJ, Hoffman KE

    . Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy. Prostate Cancer Prostatic Dis 20(4):389-394, 2017. e-Pub 2017. PMID: 28462945.

  52. Chun SG, Solberg TD, Grosshans DR, Nguyen QN, Simone CB, Mohan R, Liao Z, Hahn SM, Herman JM, Frank SJ

    . The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer. Front Oncol 7:201, 2017. e-Pub 2017. PMID: 28929085.

  53. Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DC

    . Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg 154(2):689-699, 2017. e-Pub 2017. PMID: 28495066.

  54. Yang J, Xu T, Gomez DR, Yuan X, Nguyen QN, Jeter M, Song Y, Hahn S, Liao Z

    . Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer. Oncotarget 8(26):43080-43090, 2017. PMID: 28574846.

  55. Chance WW, Nguyen QN, Mehran R, Welsh JW, Gomez DR, Balter P, Komaki R, Liao Z, Chang JY

    . Stereotactic ablative radiotherapy for adrenal gland metastases: factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. Pract Radiat Oncol 7(3):195-203, 2017. e-Pub 2016. PMID: 27743801.

  56. Yue J, McKeever M, Sio TT, Xu T, Huo J, Shi Q, Nguyen QN, Komaki R, Gomez DR, Pan T, Wang XS, Liao Z

    . Association of Lung Fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer. Clin Transl Radiat Oncol 11(4):1-7, 2017.

  57. Reddy JP, Tang C, Shih T, Kim B, Kim C, Nguyen QN, Welsh J, Benveniste M, Zhang J, Liao Z, Gomez DR

    . Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer. Clin Lung Cancer 18(2):141-148, 2017. e-Pub 2016. PMID: 27913215.

  58. Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU

    . Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol 12(2):375-382, 2017. e-Pub 2016. PMID: 27794500.

  59. Liao L, Lim GJ, Li Y, Yu J, Sahoo N, Li H, Gillin M, Zhu XR, Mahajan A, Frank SJ, Grosshans DR, Nguyen QN, Gomez D, Zhang X

    . Robust Optimization for Intensity Modulated Proton Therapy plans with multi-isocenter large fields. International Journal of Particle Therapy 3(2):305-311, 2016.

  60. Li P, Wang X, Liu Z, Liu H, Xu T, Wang H, Gomez DR, Nguyen QN, Wang LE, Teng Y, Song Y, Komaki R, Welsh JW, Wei Q, Liao Z

    . Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer. Clin Lung Cancer 17(4):253-262.e5, 2016. e-Pub 2015. PMID: 26732495.

  61. Pugh TJ, Choi S, Nogueras-Gonzalaez GM, Nguyen QN, Mahmood U, Frank SJ, Mathai B, Zhu XR, Sahoo N, Gillin M, Kuban DA, Hoffman KE, McGuire SE, Lee AK

    . Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trial. International Journal of Particle Therapy 3(1):27-36, 2016.

  62. Nguyen QN, Ly NB, Komaki R, Levy LB, Gomez DR, Chang JY, Allen PK, Mehran RJ, Lu C, Gillin M, Liao Z, Cox JD

    . Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer. Radiother Oncol 115(3):367-72, 2015. e-Pub 2015. PMID: 26028228.

  63. Tang C, Gomez DR, Wang H, Levy LB, Zhuang Y, Xu T, Nguyen QN, Komaki R, Liao Z

    . Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88(2):319-25, 2014. PMID: 24411603.

  64. Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK

    . Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 87(5):946-53, 2013. e-Pub 2013. PMID: 24139077.

  65. Wang H, Liao Z, Zhuang Y, Xu T, Nguyen QN, Levy LB, O’Reilly M, Gold KA, Gomez DR

    . Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database. Int J Radiat Oncol Biol Phys 87(5):1071-7, 2013. e-Pub 2013. PMID: 24161424.

  66. Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA

    . Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer 119(18):3265-71, 2013. e-Pub 2013. PMID: 23798338.

  67. Kim SH, Choi JB, Nguyen QN, Lee JM, Park S, Chung TD, Byun JY

    . Nanoporous platinum thin films synthesized by electrochemical dealloying for nonenzymatic glucose detection. Phys Chem Chem Phys 15(16):5782-7, 2013. e-Pub 2013. PMID: 23361231.

  68. Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA

    . Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?. Int J Radiat Oncol Biol Phys 85(3):693-9, 2013. e-Pub 2012. PMID: 22836052.

  69. McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA

    . PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era. Int J Radiat Oncol Biol Phys 85(1):e39-46, 2013. e-Pub 2012. PMID: 23102837.

  70. Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE

    . Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol 23(9):2346-52, 2012. e-Pub 2012. PMID: 22357249.

  71. Sharp HJ, Swanson D, Pugh TJ, Kudchadker R, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman K, McGuire S, Frank SJ

    . Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Practical Radiation Oncology 2(3):e7-e13, 2012. e-Pub 2012. PMID: 24674130.

  72. Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen QN, Lee AK

    . Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med 28(3):240-4, 2012. e-Pub 2011. PMID: 21875820.

  73. Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA

    . Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?. Eur J Cancer 48(11):1664-71, 2012. e-Pub 2012. PMID: 22336663.

  74. Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ

    . Long-term tumor control after brachytherapy for base-of-prostate cancer. J Contemp Brachytherapy 3(4):183-187, 2011. PMID: 23346126.

  75. Zhu XR, Poenisch F, Song X, Johnson JL, Ciangaru G, Taylor MB, Lii M, Martin C, Arjomandy B, Lee AK, Choi S, Nguyen QN, Gillin MT, Sahoo N

    . Patient-Specific Quality Assurance for Prostate Cancer Patients Receiving Spot Scanning Proton Therapy Using Single-Field Uniform Dose. Int J Radiat Oncol Biol Phys 81(2):552-9, 2011. e-Pub 2011. PMID: 21300457.

  76. Meyer J, Bluett J, Amos R, Levy L, Choi S, Nguyen QN, Zhu XR, Gillin M, Lee A

    . Spot Scanning Proton Beam Therapy for Prostate Cancer: Treatment Planning Technique and Analysis of Consequences of Rotational and Translational Alignment Errors. Int J Radiat Oncol Biol Phys 78(2):428-434, 2010. e-Pub 2010. PMID: 20100641.

  77. Nguyen QN, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, Chang EL

    . Management of Spinal Metastases from Renal Cell Carcinoma Using Stereotactic Body Radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185-92, 2010. e-Pub 2009. PMID: 19632064.

  78. Darus CJ, Callahan MB, Nguyen QN, Pastore LM, Schneider BF, Rice LW, Jazaeri AA

    . Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma. Int J Gynecol Cancer 18(4):730-5. e-Pub 2007. PMID: 17949426.

  79. Nguyen QN, Chang EL, Allen PK, Maor MH, Ater JL, Mahajan A, Wolff JE, Weinberg JS, Woo SY

    . Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer 107(9):2228-36, 2006. PMID: 17019739.

  80. Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen QN, Janjan NA

    . Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-FU-based chemoradiation in locally advanced pancreatic cancer?. Int J Radiat Oncol Biol Phys 52(5):1293-1302, 2002. PMID: 11955742.

  81. Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PWT, Lee JE, Lenzi R, Vauthey NJ, Wong A, Phan T, Nguyen QN, Abbruzzese JL.

    . Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 29(1):9-18, 2001. PMID: 11560155.

Bài viết liên quan
Alternate Text Gọi ngay